Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS)

被引：20

作者：

Cheung, Shan ^{[1
]}

Booth, Mary E. ^{[2
]}

Kearins, Olive ^{[1
]}

Dodwell, David ^{[3
]}

机构：

[1] Publ Hlth England West Midlands, Birmingham B3 2PW, W Midlands, England

[2] Univ Leeds, Sch Med, Leeds LS2 9NL, W Yorkshire, England

[3] St James Hosp, Inst Oncol, Leeds LS9 7TF, W Yorkshire, England

来源：

BREAST | 2014年 / 23卷 / 06期

关键词：

DCIS; NHSBSP (NHS breast screening programme); Breast cancer; Radiotherapy; Recurrence; SURGICAL ADJUVANT BREAST; TRIAL; RADIOTHERAPY; RECURRENCE; TAMOXIFEN; WOMEN;

D O I：

10.1016/j.breast.2014.08.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Despite surgical removal of ductal carcinoma in situ (DCIS), recurrences still occur. This retrospective cohort study evaluated the risk of invasive recurrence following surgery and investigated factors which may be predictive of recurrence. We specifically investigated invasive recurrence with respect to mode of detection of DCIS. Patients whose DCIS was detected outside of the NHS Breast Screening Programme have a higher risk of subsequent ipsilateral invasive breast cancer than those whose DCIS is detected through screening. There is no significant difference in risk of subsequent contralateral invasive recurrence according to mode of detection. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：807 / 811

页数：5

共 15 条

[1] Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial [J].

Cuzick, Jack ;

Sestak, Ivana ;

Pinder, Sarah E. ;

Ellis, Ian O. ;

Forsyth, Sharon ;

Bundred, Nigel J. ;

Forbes, John F. ;

Bishop, Hugh ;

Fentiman, Ian S. ;

George, William D. .

LANCET ONCOLOGY, 2011, 12 (01) :21-29

[2] Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial [J].

Donker, Mila ;

Litiere, Saskia ;

Werutsky, Gustavo ;

Julien, Jean-Pierre ;

Fentiman, Ian S. ;

Agresti, Roberto ;

Rouanet, Philippe ;

de lara, Christine Tunon ;

Bartelink, Harry ;

Duez, Nicole ;

Rutgers, Emiel J. T. ;

Bijker, Nina .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) :4054-4059

[3] Second events following ductal carcinoma in situ of the breast: a register-based cohort study [J].

Falk, Ragnhild Sorum ;

Hofvind, Solveig ;

Skaane, Per ;

Haldorsen, Tor .

BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (03) :929-938

[4] Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial [J].

Fisher, B ;

Dignam, J ;

Wolmark, N ;

Wickerham, DL ;

Fisher, ER ;

Mamounas, E ;

Smith, R ;

Begovic, M ;

Dimitrov, NV ;

Margolese, RG ;

Kardinal, CG ;

Kavanah, MT ;

Fehrenbacher, L ;

Oishi, RH .

LANCET, 1999, 353 (9169) :1993-2000

[5]

Fisher ER, 1999, CANCER-AM CANCER SOC, V86, P429, DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO

[6]

2-Y

[7] A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].

GRAY, RJ .

ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154

[8] Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy [J].

Kerlikowske, K ;

Molinaro, A ;

Cha, I ;

Ljung, BM ;

Ernster, VL ;

Stewart, K ;

Chew, K ;

Moore, DH ;

Waldman, F .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (22) :1692-1702

[9]

National Cancer Intelligence Network, 2011, 2 NAT CANC INT NETW

[10]

NHS Breast Screening Programme and Association of Breast Surgery, 2014, AUD SCREEN DET BREAS

← 1 2 →